HopeStage
Back to all studies
TerminatedEUCTR 2004-000686-35

A 52-week open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2000 mg/d in the treatment of manic episodes of Bipolarity type I

This historical record does not confirm current site availability.

Historical research recordFinland
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Finland
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Terminated
Enrollment listed in the registry
215
Sponsor
Novartis Pharma AG
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Finland
Age range
Not clearly listed
Official registry ID
EUCTR 2004-000686-35
Official title
Show the full official title

A 52-week open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2000 mg/d in the treatment of manic episodes of bipolar I disorder

Recruitment & locations

Terminated

Finland

Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Novartis Pharma AG, a pharmaceutical company.

Is this study still recruiting?

The historical registry lists this study as terminated.

Want to explore more studies?

Explore studies